You Position: Home > Paper
Protection of cytidine deaminase gene gainst toxicity of high-dose chemotherapy in mice
( views:131, downloads:12 )
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 14
- DOI:
- 10.3969/j.issn.1009-3079.2005.14.014
- Key Word:
- 胞苷脱氨基酶基因;基因疗法;阿糖胞苷
Abstract： 目的:将人胞苷脱氨基酶基因(CD)导入小鼠骨髓细胞后,观察小鼠对大剂量阿糖胞苷(Ara-C)的耐受性,探讨骨髓耐受联合化疗的可行性.方法:以反转录病毒为载体,将人胞苷脱氨基酶基因(CD)通过共培养转染入小鼠骨髓干细胞,观察共培养后的骨髓细胞及受体小鼠骨髓移植后经药物处理后的骨髓细胞耐Ara-C CFU-GM生成情况;从转基因小鼠骨髓细胞提取DNA,用PCR检测转基因小鼠骨髓细胞耐药基因的表达;观察转基因小鼠经大剂量Ara-C化疗后血象、体质量及生存率的变化.结果:骨髓移植前共培养后供体的骨髓细胞和骨髓移植后受体含有耐药基因(SFG-CD)的骨髓细胞均有耐药克隆的形成(52%,54%;与对照组相比χ2分别为124.62,126.26,P均<0.01),并明显增加了对Ara-C的耐受性;与对照组比较含耐药基因组动物经大剂量化疗后,生存率明显提高(χ2=7.42,P<0.01),血象、体质量下降幅度较小而恢复较快;转基因小鼠骨髓细胞经PCR检测,显示有CD基因条带.结论:耐药基因可以进入小鼠骨髓细胞并且获得共表达,提高了造血细胞对Aar-C的耐受性.
- [1]Henriette Gourdeau,Lucie Bibeau,France Ouellet,etc.Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity[J].2001,47(3).
- [2]Al Khaldi A,Momparler LF,Momparler RL,etc.Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.[J].2002,9(7).
- [3]Banerjee D,Bertino JR,Zhao SC,etc.Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells.[J].2001,8(12).
- [4]Beausejour CM,Eliopoulos N,Momparler L,etc.Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.[J].2001,8(9).
- [5]Bertino JR,Takebe N,Moore MA,etc.Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.[J].2002,9(3).